Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02596711 · ClinicalTrials.gov registry record · Phase 1
Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT02596711: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT02596711 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 26 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02596711, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The goal of this research study is to learn how 3 different kinds of counseling treatments may help individuals to quit smoking.
Primary Outcome
The central aim of this pilot study was to evaluate the feasibility and acceptability of our treatment interventions. As such, we examined between-group differences on session satisfaction. After completing each session, participants anonymously rated their level of satisfaction with the counseling session. This investigator created scale (Session Satisfaction Scale) used a 5-point Likert scale (from 1 = "Extremely Unsatisfied" to 5 = "Extremely Satisfied"). Mean satisfaction scores were compute
Interventions
- BEHAVIORAL Questionnaires
- DRUG Nicotine Patch
- OTHER Carbon Monoxide (CO) Test
- BEHAVIORAL Health Education and Handouts
- BEHAVIORAL Culturally Tailored Reading Materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-11-02 |
| Est. Completion | 2017-08-22 |
| Phase | Phase 1 |
What the finished NCT02596711 record still lists
NCT02596711 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 5 interventions - of which Questionnaires is the first listed.
NCT02596711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02596711 about?
NCT02596711 is a clinical study titled "Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers". The goal of this research study is to learn how 3 different kinds of counseling treatments may help individuals to quit smoking.
What is the current status of trial NCT02596711?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2015-11-02. Estimated completion is 2017-08-22.
What interventions are being tested in trial NCT02596711?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Nicotine Patch (DRUG), Carbon Monoxide (CO) Test (OTHER), Health Education and Handouts (BEHAVIORAL), Culturally Tailored Reading Materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT02596711?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02596711's enrollment target sits among peer trials
26 1482nd of 2000 higher than 506 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI